Streetbeat News

Stock Prices

BDRX

Shares of Biodexa Pharmaceuticals resumed trading, only to be halted again due to a circuit breaker to the upside. The stock is now up by 90.1%.

Portfolio Pulse from Happy Mohamed

July 11, 2023 | 4:42 pm

TAOP

Taoping Inc. reported a 95% YoY increase in its 1H 2023 contract revenue, which amounted to approximately $14.65 million. This news has led to a rise in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 4:42 pm

KSCP

Knightscope's shares are trading higher following the announcement that Georgia State University has chosen Knightscope Authorized Partner TS&L to supply and install K1 Blue Light Towers and Call Boxes at its downtown Atlanta campus.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 4:41 pm

AVTA

Avantax is reportedly exploring a potential sale, which has led to an increase in its share prices.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 4:41 pm

TTD

A significant bullish stance has been taken on Trade Desk (NASDAQ:TTD) with 10 uncommon options trades spotted. The sentiment of these big-money traders is split between 70% bullish and 30% bearish. The whales have been targeting a price range from $75.0 to $85.0 for Trade Desk over the last 3 months. The price of TTD is up 6.34% at $80.72. Needham has downgraded its action to Buy with a price target of $80.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 4:33 pm

CRWD

A significant amount of unusual options activity has been observed for CrowdStrike Holdings (NASDAQ:CRWD), with a majority of investors taking a bearish stance. Whales have been targeting a price range from $125.0 to $160.0 for CrowdStrike over the last 3 months. The company's stock price is currently up 0.73% at $151.05. Analysts from Needham, Mizuho, and Keybanc have given price targets of $170, $180, and $200 respectively.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 4:33 pm

BDRX

Shares of Biodexa Pharmaceuticals were halted on a circuit breaker to the upside, with the stock now up by 51.9%.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 4:33 pm

RMTI

Rockwell Medical Inc (RMTI) has acquired the hemodialysis concentrates business from Evoqua Water Technologies. The deal includes $11 million upfront in cash and two milestone payments of $2.5 million each. The acquisition will expand Rockwell's footprint in the U.S. and increase its market share in the hemodialysis concentrates market. Following the acquisition, Rockwell has increased its FY23 revenue guidance to $82 million-$86 million. Despite the positive news, RMTI shares are trading lower.

Portfolio Pulse from Vandana Singh

July 11, 2023 | 4:30 pm

AZO

AutoZone (NYSE:AZO) has outperformed the market over the past 10 years by 9.2% on an annualized basis, producing an average annual return of 19.38%. If an investor had bought $100 of AZO stock 10 years ago, it would be worth $582.04 today.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 4:30 pm

MA

Mastercard (NYSE:MA) has outperformed the market over the past 10 years by 10.83% on an annualized basis, producing an average annual return of 21.0%. If an investor had bought $1000 of MA stock 10 years ago, it would be worth $6,659.50 today.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 4:30 pm